LE Paper 15 · Topic 2
The Listing Rules and the IPO listing process
A sponsor Principal must judge whether a client can list and how its offer will be built, so this topic is heavy on rules and figures. The shared sections cover methods of listing, Main Board and GEM eligibility (including the weighted voting rights, biotech and specialist technology routes), secondary listings, the board, the application procedure, listing document content and the Guide for New Listing Applicants. Paper 15 adds three outcomes for Principals: the financial reporting and compliance points that decide whether a timetable holds (the three-year accountants' report and the six-month rule, non-compliances, lock-ups); other matters that shape the application (connected transactions, competition with controlling shareholders, pre-IPO and cornerstone investors, spin-offs); and how shares are allocated and supported after listing (Practice Note 18 as revised on 4 August 2025, Appendix F1 consents, price stabilisation under Cap. 571W and the overall coordinator's duties in Code of Conduct paragraph 21). Expect calculations on clawback, the 40% placing floor and stabilizing price limits.
55 min read28 sections
Main Board Listing Rules Chapters 4, 7, 8, 8A, 18A, 18C and 19C and rule 1.01, and GEM Listing Rules Chapter 11, current text on the HKEX rulebook (including Update No. 150 effective 4 August 2025 and Update No. 154 of July 2026); HKEX Guide for New Listing Applicants (consolidated July 2026) chapters 2.2, 2.3, 2.5 and 4.15. Checked 14 November 2026. Added 21 November 2026: HKEX consultation conclusions on the listing framework competitiveness review (24 July 2026) on Chapter 18A/18C route choice. Checked as at 14 November 2026: HKEX Main Board Listing Rules (current rulebook text) Chapters 3, 3A (rr.3A.02-3A.02B), 9, 10, 11, 11A and 12 and Appendix D1A; HKEX Guide for New Listing Applicants (July 2026) Introduction, Chapters 1, 1.2C, 4.14, 6.2-6.6 and Annex B.5; e-Legislation: Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) ss.38D, 342C; Securities and Futures (Stock Market Listing) Rules (Cap. 571V) ss.2-9. Added 21 November 2026: HKEX consultation conclusions on the listing framework competitiveness review (24 July 2026, non-public filing for all new applicants); SFC and HKEX Joint Statement on Enhanced Timeframe for New Listing Application Process (18 October 2024); SFC consultation conclusions on amendments to the Securities and Futures (Stock Market Listing) Rules (12 October 2026). Checked as at 14 November 2026: HKEX Main Board Listing Rules (current rulebook text) rr.3A.19, 4.03-4.11, 4.05A, 8.06, 8.10, 10.07, 10.08, 14A.52, 14A.53, 14A.105, Practice Note 15, Practice Note 18 (revised 4 August 2025) and Appendix F1; HKEX Guide for New Listing Applicants (July 2026) chapters 1.2D, 3.7, 3.8, 3.9, 3.11, 4.2, 4.14 and 4.15; Securities and Futures (Price Stabilizing) Rules (Cap. 571W) on e-Legislation (version of 24 September 2026); SFC Code of Conduct (December 2025 edition) paragraph 21. Added 21 November 2026: HKEX consultation conclusions on ongoing public float requirements (17 December 2025; rules and Guidance Letter HKEX-GL121-26 effective 1 January 2026); HKEX consultation paper on Phase 2 of the listing framework competitiveness review (21 September 2026, closing 30 November 2026) on Practice Note 15; HKEX consultation conclusions on IPO price discovery and open market requirements (1 August 2025, effective 4 August 2025). Independent prep, not endorsed by HKSI Institute or the SFC.
Must-know for the exam
- Main Board tests (rule 8.05): profit HK$35m latest year plus HK$45m for the two before; or HK$2bn cap, HK$500m revenue, HK$100m cash flow; or HK$4bn cap, HK$500m revenue.
- Public float at listing (rule 8.08(1), from 4 August 2025): 25% up to HK$6bn; then the higher of 15% or HK$1.5bn; above HK$30bn the higher of 10% or HK$4.5bn.
- Free float (rule 8.08A): unrestricted public shares of at least 10% and HK$50m, or at least HK$600m. Every applicant also needs HK$500m market capitalisation and HK$125m in public hands (rule 8.09).
- WVR listing (rule 8A.06, July 2026): HK$20bn cap, or HK$6bn cap with HK$600m revenue; new applicants only; vote ratio capped at 10:1, or 20:1 at HK$40bn or more.
- Board: at least 3 INEDs making up one-third of the board, one with accounting or financial expertise; independence is questioned above a 1% holding (Main Board Rules 3.10, 3.10A, 3.13).
- The Application Proof must be substantially complete; a returned applicant may refile only 8 weeks after the Returned Date, and the return is published (Rule 9.03(3); Guide 6.2).
- Core connected persons may not deal from 4 clear business days before the expected hearing until listing; controlling shareholders: 6-month lock-up, then 6 months keeping control (Rules 9.09(b), 10.07).
- The Exchange authorises prospectus registration and the Registrar registers it by publication (Cap. 32 s.38D); the SFC grants exemptions and may object to listing within 10 business days (Cap. 571V s.6).
- Practice Note 18 (revised 4 August 2025): Mechanism A starts the public tranche at 5%, clawback to 15%, 25%, 35% at 15x, 50x, 100x; Mechanism B starts at 10% minimum, no clawback.
- Rule 8.06: the latest period in the accountants' report must end no more than six months before the listing document date; stub figures audited, comparatives at least reviewed (Guide 3.11).
On this page · 28 sections
Methods of listing and offering mechanisms (Chapter 7)
Chapter 7 of the Main Board Listing Rules lists the ways equity securities come to listing. Four matter for an IPO:
| Method | What it is | Key condition |
|---|---|---|
| Offer for subscription | Issuer offers its own new securities to the public (r.7.02) | Must be fully underwritten (r.7.03); listing document (r.7.05) |
| Offer for sale | Holders of securities already in issue offer them to the public (r.7.06) | Listing document (r.7.08); fair basis of allotment in a tender (r.7.07) |
| Placing | Securities sold mainly to persons selected or approved by the issuer or an intermediary (r.7.09) | Placing guidelines in Appendix F1; no placing-only IPO if significant public demand is likely (r.7.10) |
| Introduction | Listing of securities already in issue and so widely held that no marketing is needed (r.7.13) | Listing document (r.7.17); apply early, naming the ten largest beneficial holders and total holders (r.7.16) |
Introductions normally suit three cases (r.7.14): securities already listed on another stock exchange, a distribution in specie by a listed issuer, and a new holding company issued in exchange for listed securities. Rule 7.15 limits them: only in exceptional circumstances if the securities were marketed in Hong Kong in the previous six months conditional on listing; not if there is a pre-existing intention to dispose, likely significant public demand or an intended change in the issuer's circumstances; never if a change in the nature of the business is in contemplation.
Chapter 7 also covers methods for issuers already listed: rights issues, open offers, capitalisation issues, consideration issues and exchanges, and the exercise of options and warrants. A transfer from GEM to the Main Board follows Chapters 9A and 9B (r.7.35).
Offering mechanism. A typical Main Board IPO combines a public subscription tranche (an offer to the public in Hong Kong) with a placing tranche, usually bookbuilt and marketed to institutional and professional investors, often including cornerstone investors who commit before the price is set. How shares are split between the tranches is governed by Practice Note 18 and is not covered in this section.
Trap: Calling every public offer an offer for subscription. Ask whose shares are sold: the issuer's new shares (subscription) or holders' existing shares (sale). An introduction sells nothing but still needs a listing document.
Takeaway: Subscription = issuer's new shares, fully underwritten. Sale = holders' shares. Placing = selected investors. Introduction = widely held, no marketing, listing document still needed.
Main Board financial tests (rule 8.05)
Rule 8.05 requires a Main Board new applicant to meet one of three financial tests. Each also needs a trading record of at least three financial years, management continuity for at least the three preceding financial years and ownership continuity and control for at least the most recent audited financial year.
| Test | Market capitalisation at listing | Other financial limbs |
|---|---|---|
| Profit test (r.8.05(1)) | HK$500m minimum under r.8.09(2) | Profit attributable to shareholders of at least HK$35m in the latest year and HK$45m in aggregate for the two preceding years |
| Market cap/revenue/cash flow (r.8.05(2)) | At least HK$2bn | Revenue at least HK$500m for the latest audited year; positive operating cash flow at least HK$100m in aggregate over three years |
| Market cap/revenue (r.8.05(3)) | At least HK$4bn | Revenue at least HK$500m for the latest audited year |
What counts. The profit test is applied to the group excluding associates and other equity-accounted entities, and excludes income or loss outside the ordinary and usual course of business (r.8.05(1)(a)). For the two revenue tests, only revenue from principal activities counts; incidental gains and book transactions such as banner barter or written-back provisions are disregarded (r.8.05(4)).
Trap: Testing the headline numbers. Strip out one-off gains before the profit test and barter revenue before the revenue tests, and remember the cash flow limb is a three-year aggregate, not a yearly figure.
Takeaway: Profit HK$35m + HK$45m; HK$2bn cap with HK$500m revenue and HK$100m cash flow; or HK$4bn cap with HK$500m revenue.
Trading record, management and ownership continuity
Three years is the default Main Board trading record (rules 8.05 and 4.04). The continuity rules make sure the record reflects the business and people being listed.
- •Management continuity: at least the three preceding financial years (r.8.05(1)(b), (2)(b), (3)(b)).
- •Ownership continuity and control: at least the most recent audited financial year (r.8.05(1)(c)). The note to r.8.05 calls that year up to just before listing the Relevant Period. A change of controlling shareholder in it is acceptable only if the applicant shows no material change in influence on management; otherwise the Exchange may see packaging.
- •Shorter record under the market cap/revenue test (r.8.05A): accepted if directors and management have at least three years' experience in the line of business and industry (disclosed in the listing document) and there is management continuity for the most recent audited financial year.
| Case under r.8.05B | What the Exchange may relax |
|---|---|
| Mineral companies under Chapter 18 | Shorter trading record; vary the financial standards |
| Newly formed infrastructure project companies | Same, if the company has the right to build and operate the project, a government concession normally with at least 15 years left, a capital cost share normally at least HK$1bn, and uses the bulk of the proceeds for construction, not mainly to repay debt |
| Exceptional circumstances | A trading record of at least two financial years, if listing is desirable and investors have the information they need |
Trap: Treating a stable board as proof of ownership continuity. The two continuity tests are separate, and the ownership period runs right up to listing.
Takeaway: Three years' trading and management, latest audited year's ownership; rule 8.05A relaxes the record only under the HK$4bn/HK$500m test.
Public float, free float and market value (rules 8.08-8.09)
There must be an open market in the securities (r.8.08). Since 4 August 2025, the minimum public float at listing depends on the expected market value of the class being listed (shares in issue at listing, excluding treasury shares):
| Expected market value of the class | Minimum held by the public at listing (r.8.08(1)) |
|---|---|
| Up to HK$6bn | 25% |
| Over HK$6bn up to HK$30bn | Higher of 15% and the percentage giving public holdings worth HK$1.5bn |
| Over HK$30bn | Higher of 10% and the percentage giving public holdings worth HK$4.5bn |
- •Spread: at least 300 shareholders at listing (r.8.08(2)); the three largest public shareholders may own no more than 50% of the shares in public hands (r.8.08(3)).
- •Free float (r.8.08A): public shares free of any disposal restriction must be at least 10% of the class and worth at least HK$50m, or be worth at least HK$600m. Locked-up shares, such as cornerstone shares in their six-month lock-up, count towards public float if the holder is public (Guide chapter 4.15) but not towards free float.
- •Market value (r.8.09): public holdings worth at least HK$125m; market capitalisation at least HK$500m (all issued shares, excluding treasury shares); each class at least HK$50m (warrants HK$10m).
- •Who is not "the public" (r.8.24): core connected persons (directors, chief executive and substantial shareholders, meaning 10% or more of the votes, of the issuer or any subsidiary, and their close associates); anyone whose purchase was financed by the issuer or a core connected person; anyone accustomed to take their instructions on the shares; and the issuer itself as holder of treasury shares.
Worked example: a class worth HK$8bn needs the higher of 15% and HK$1.5bn / HK$8bn = 18.75%, so 18.75%.
1. A class has an expected market value of HK$20bn at listing. What minimum public float applies?
15%. HK$1.5bn is only 7.5% of HK$20bn, so the 15% limb is the higher one (r.8.08(1)).
2. Expected market value HK$40bn. Minimum public float?
The higher of 10% and HK$4.5bn / HK$40bn = 11.25%, so 11.25%.
3. Do cornerstone shares still inside their six-month lock-up count towards free float?
No. They can count towards public float if the holder is a member of the public, but free float counts only shares free of disposal restrictions (r.8.08A).
4. Minimum Main Board market capitalisation and public holding value at listing?
HK$500m market capitalisation and at least HK$125m held by the public (r.8.09).
Trap: Stopping at the 15% or 10% headline. In the top two bands the HK$1.5bn or HK$4.5bn value limb often gives the higher figure. And public float and free float are separate tests.
Takeaway: 25% / 15%-or-HK$1.5bn / 10%-or-HK$4.5bn; free float 10% and HK$50m or HK$600m; 300 holders; HK$125m public; HK$500m cap.
Suitability and other basic conditions (Chapter 8)
Passing a financial test does not make an applicant listable. The Exchange keeps an absolute discretion and compliance with Chapter 8 does not of itself ensure suitability (r.8.01). Both the issuer and its business must be suitable (r.8.04).
| Condition | Rule |
|---|---|
| Duly incorporated and in line with its constitution and local law | r.8.02 |
| Regulators of the place of incorporation and of central management and control are full signatories to the IOSCO MMOU (waivable only with the SFC's explicit consent) | r.8.02A, 8.02B |
| A Hong Kong company must not be a private company | r.8.03 |
| Not suitable if group assets are wholly or substantially cash and short-term investments (investment companies follow Chapter 21) | r.8.05C |
| Adequate market: sufficient public interest in the business and the securities | r.8.07 |
| Controlling shareholder's competing (excluded) business: prominent disclosure, independence at arm's length; later acquisition must meet r.8.05 | r.8.10 |
| No shares whose voting power bears no reasonable relationship to equity (B Shares), except as Chapter 8A or 19C permits | r.8.11 |
| Freely transferable; partly-paid securities can qualify if transfer is not unreasonably restricted | r.8.13 |
| Eligible Securities for CCASS from the first day of dealings | r.8.13A |
Trap: Thinking a competing business or a cash-rich balance sheet can be fixed by a sponsor's confirmation. The first is handled by disclosure and independence; the second makes the applicant unsuitable.
Takeaway: Meeting rule 8.05 is necessary, not sufficient: suitability, IOSCO MMOU, public company, transferable, CCASS-eligible, no B Shares outside Chapter 8A.
Weighted voting rights (Chapter 8A)
Chapter 8A lets an innovative company list with weighted voting rights (WVR). The thresholds were lowered in July 2026 (Update No. 154). The Guide for New Listing Applicants (chapter 2.2) adds suitability tests: innovative company, high growth, each beneficiary an individual with an active executive role who contributed materially to growth, and meaningful investment from at least one sophisticated investor that stays in at IPO.
| Requirement | Rule | Figure |
|---|---|---|
| Who may apply | r.8A.05 | New applicants only; a listed issuer cannot adopt WVR |
| Financial threshold | r.8A.06 | Market capitalisation at least HK$20bn, or at least HK$6bn with revenue at least HK$600m for the latest audited year (before July 2026: HK$40bn, or HK$10bn with HK$1bn revenue) |
| WVR class | r.8A.07-8A.08 | Enhanced votes at general meetings only; the WVR class itself is not listed |
| Votes of non-WVR holders | r.8A.09 | At least 10% of the votes eligible to be cast |
| Voting ratio cap | r.8A.10 (from 24 July 2026) | 20 times an ordinary share if market capitalisation at listing is at least HK$40bn; 10 times otherwise |
| Beneficiaries | r.8A.11 | Must be directors at listing |
| Economic interest | r.8A.12 | Beneficiaries together at least 10% at listing; the Exchange may accept at least 5% and at least HK$4bn |
After listing, WVR end if the beneficiary dies, leaves the board or is found unfit (r.8A.17), or transfers the shares (r.8A.18); conversion is one-for-one (r.8A.21). Certain resolutions, such as changes to the constitution and appointing or removing INEDs or auditors, are voted on a one vote per share basis (r.8A.24).
Trap: Using the 2018 figures (HK$40bn, or HK$10bn with HK$1bn revenue; flat 10:1). They changed in July 2026.
Takeaway: WVR: new applicants only; HK$20bn, or HK$6bn plus HK$600m revenue; 10:1 cap, 20:1 at HK$40bn+; others keep 10% of votes.
Biotech and specialist technology companies (Chapters 18A and 18C)
Two Main Board chapters let biotech and specialist technology companies list without passing a rule 8.05 financial test. Both still apply the rest of Chapter 8, including public float and free float.
Recent change · 24 July 2026
A biotech or specialist technology applicant that does meet a rule 8.05 test may now still choose the Chapter 18A or 18C route. Before this, the specialist chapters were for companies that could not meet the ordinary financial tests (HKEX consultation conclusions on the listing framework competitiveness review, July 2026).
| Point | Chapter 18A Biotech Company | Chapter 18C Specialist Technology Company |
|---|---|---|
| Who | Primarily engaged in R&D, application and commercialisation of Biotech Products | Primarily engaged in R&D and commercialisation of Specialist Technology Products in an acceptable sector |
| Market capitalisation at listing | At least HK$1.5bn (r.18A.03(2)) | Rule 18C.03(3): HK$6bn Commercial, HK$10bn Pre-Commercial, temporarily HK$4bn and HK$8bn from 1 September 2024 to 31 August 2027 |
| Operating record | Two financial years under substantially the same management (r.18A.03(3)) | Three financial years under substantially the same management (r.18C.03(2)); R&D for at least three years (r.18C.04(1)) |
| Revenue | None required | Commercial Company: at least HK$250m in the latest audited year (r.18C.03(4)) |
| R&D intensity | Not a rule test | At least 15% of operating expenditure (Commercial); 30% (Pre-Commercial, revenue HK$150m-250m); 50% (Pre-Commercial, revenue under HK$150m); met in at least two of three years and in aggregate (r.18C.04) |
| Working capital | 125% of group costs for 12 months after the listing document (r.18A.03(4)) | Same for a Pre-Commercial Company (r.18C.07) |
| Investor validation | At least one sophisticated investor with a meaningful investment at least six months before listing (Guide ch. 2.3) | Meaningful investment from sophisticated independent investors (r.18C.05); Pathfinder investors in at least 12 months before the application (Guide ch. 2.5) |
For a drug, the Guide (chapter 2.3) treats a Core Product as beyond the concept stage if it has completed Phase I and the Competent Authority (US FDA, China's NMPA or the European Medicines Agency) has not objected to Phase II. A Chapter 18A issuer carries the stock marker "B" (r.18A.11), unless as a new applicant it met a rule 8.05 test (r.18A.13).
Trap: Mixing the two chapters: two years and six months for biotech; three years and 12 months for specialist technology. And quoting the 18C rule figures without the temporary HK$4bn/HK$8bn modification.
Takeaway: 18A: HK$1.5bn, two years, Phase I done. 18C: HK$4bn/HK$8bn until August 2027, three years, R&D 15%/30%/50%.
GEM eligibility (GEM Chapter 11)
GEM serves small and mid-sized companies. Its eligibility test changed on 1 January 2024, adding a route for R&D-intensive companies. A sponsor is required (GEM Chapter 6A).
| Point | GEM (Chapter 11) | Main Board, for comparison |
|---|---|---|
| Trading record | Two financial years (r.11.12A) | Three financial years (r.8.05) |
| Financial test | Cash flow: positive operating cash flow before working capital changes and taxes of at least HK$30m over the two years; or market cap/revenue/R&D: HK$250m cap, HK$100m revenue over two years with year-on-year growth, HK$30m R&D over two years, R&D at least 15% of operating expenditure each year | Rule 8.05 tests |
| Management continuity | Two full financial years before the listing document, up to listing (r.11.12A(3)) | Three financial years |
| Ownership continuity | Full financial year before the listing document, up to listing (r.11.12A(2)) | Most recent audited financial year |
| Market capitalisation | At least HK$150m (r.11.23(6)) | At least HK$500m |
| Public float value and spread | HK$45m; guideline of 100 public holders (r.11.23(2)) | HK$125m; 300 shareholders |
| Public float percentage | Same three bands as the Main Board (r.11.23(7)) | r.8.08(1) |
| Free float | 10% and HK$15m, or HK$600m (r.11.23A) | 10% and HK$50m, or HK$600m |
| Partly-paid shares | Not admissible (r.11.27) | Can qualify (r.8.13) |
If the active business sits in a subsidiary, the applicant must control the composition of that subsidiary's board and have an effective economic interest of at least 50% in it (r.11.13).
Trap: Swapping GEM's continuity periods (two years management, one year ownership) or applying Main Board value floors to GEM.
Takeaway: GEM: two years; HK$30m cash flow or the HK$250m R&D route; HK$150m cap; HK$45m public; 100 holders; free float 10% and HK$15m.
Secondary listings (Chapter 19C)
Chapter 19C lets an overseas issuer that is primary listed elsewhere add a secondary listing in Hong Kong. Listing on the primary exchange must come first (r.19C.02A(2)), and the Exchange may refuse if most worldwide trading would move to Hong Kong at or soon after listing (r.19C.02A(1)(e)). Qualifying Exchanges are the NYSE, Nasdaq and the Main Market of the London Stock Exchange. The thresholds below were lowered in July 2026.
| Issuer | Track record | Market capitalisation at listing |
|---|---|---|
| With a WVR structure (r.19C.04-19C.05) | Two full financial years of good regulatory compliance on a Qualifying Exchange | At least HK$20bn, or at least HK$6bn with revenue at least HK$600m |
| Without WVR, Criteria A (r.19C.05A(1)-(2)) | Five full financial years on a Qualifying Exchange (or any Recognised Stock Exchange if no centre of gravity in Greater China) | At least HK$3bn |
| Without WVR, Criteria B (r.19C.05A(3)-(4)) | Two full financial years on a Qualifying Exchange | At least HK$6bn |
- •A Greater China issuer without WVR primary listed on a Recognised Stock Exchange that is not a Qualifying Exchange is considered only in exceptional circumstances (note to r.19C.05A).
- •Secondary-listed issuers are exempt from a list of Main Board rules (r.19C.11) and may get further waivers (r.19C.11A).
- •If 55% or more of worldwide trading by dollar value moves to Hong Kong over a financial year, the issuer is treated as dual-primary listed and loses those exemptions, with a 12-month grace period (r.19C.13).
Trap: Pairing the wrong record with the wrong value. Five years goes with HK$3bn; two years with HK$6bn; WVR issuers need two years plus the WVR thresholds.
Takeaway: Primary listing first; trading stays mainly overseas; five years/HK$3bn or two years/HK$6bn; WVR two years plus HK$20bn, or HK$6bn and HK$600m.
Directors of the applicant: duties, legal advice and training
Chapter 3 of the Main Board Listing Rules applies to a new applicant's board from filing. The board is collectively responsible for management and operations, and each director must meet fiduciary duties and duties of skill, care and diligence at least to the standard of Hong Kong law (r.3.08). Delegation is allowed but does not shift responsibility; attending only formal meetings is not enough.
- •Fitness: character, experience, integrity and competence to match the position (r.3.09). The Guide for New Listing Applicants (Chapter 1.2C) treats fraud, deceit or dishonesty, prosecuted or not, as an Integrity Non-compliance that may make a person unsuitable as a director.
- •Compliance: comply, and use best endeavours to make the issuer comply, with the Listing Rules, the Companies Ordinance, the C(WUMP)O, the SFO and the Takeovers and Share Buy-backs Codes (r.3.09B). Cooperate with Exchange and SFC investigations, during office and after leaving (r.3.09C).
- •Legal advice: every director gets advice from a firm of solicitors qualified in Hong Kong law on their Listing Rules obligations (r.3.09D). A new applicant ensures each director at listing has it before dealings begin and discloses the date and each director's confirmation in the listing document.
- •Biographies: each director and proposed director named in the Application Proof or a later draft ensures their biographical details are true, accurate and complete, and reports changes before dealings as soon as practicable (r.9.03(3A)(b)).
- •Responsibility: directors accept full responsibility, collectively and individually, for the issuer's compliance with the Listing Rules (r.3.16) and follow the Model Code in Appendix C3 or a code no less exacting (r.3.17).
- •Contact details: given to the Exchange on appointment; changes notified within 28 days while a director and for 3 years after leaving (r.3.20).
Training. Every director receives continuous professional development (CPD) in each financial year (r.3.09F), covering board roles, directors' duties, corporate governance and ESG, risk management and industry developments (r.3.09G). First-time directors have a minimum within 18 months of appointment (r.3.09H):
| Director's background | Minimum CPD within 18 months of appointment (r.3.09H) |
|---|---|
| No Main Board or GEM directorship in the 3 years before appointment | At least 24 hours |
| Same, but a director of an issuer listed on another exchange within those 3 years | At least 12 hours |
| A Main Board or GEM director within the last 3 years | Not a first-time director; annual CPD under r.3.09F |
Trap: treating the r.3.09D legal advice as a post-listing task. For a new applicant every director at listing must have it before dealings begin, and the listing document gives the date.
Takeaway: Hong Kong-law standard of care, legal advice before dealings, CPD every year, and 24 hours within 18 months for first-time directors.
Independent non-executive directors: numbers, independence and tenure
Every board needs at least 3 INEDs, at least one with appropriate professional qualifications or accounting or related financial management expertise (r.3.10), and INEDs must make up at least one-third of the board (r.3.10A). A shortfall is announced at once and fixed within 3 months (r.3.11). The Exchange may require more than 3 INEDs where the size of the board or other circumstances justify it (r.3.12).
Independence (r.3.13). None of the factors is conclusive, but independence is more likely to be questioned if the person:
- •holds more than 1% of the issued shares, counting shares under outstanding options and convertibles; above 1% the issuer must show independence before appointing, and a 5% holder is normally not independent
- •received shares as a gift or financial assistance from a core connected person or the issuer (shares as fees or under a Chapter 17 scheme are fine)
- •is or was a director, partner or principal (or an involved employee) of a professional adviser that provides, or within 2 years provided, services to the group, its core connected persons or a controlling shareholder
- •has, or within 1 year had, a material interest in a principal business activity of, or material business dealings with, the group or its core connected persons
- •sits on the board to protect an interest different from shareholders as a whole, or is financially dependent on the group
- •is, or within 2 years was, connected with a director, the chief executive or a substantial shareholder (spouse, child, parent, sibling and step-relations count)
- •is, or within 2 years was, an executive (including company secretary) or non-independent director of the issuer, its holding company, subsidiaries or core connected persons
| Factor (r.3.13) | Marker |
|---|---|
| Shareholding | Over 1% questioned (options count); 5% or more normally not independent |
| Professional adviser to the group | Services now or within 2 years |
| Material business dealings or interest | Now or within 1 year |
| Connected with a director, chief executive or substantial shareholder | Now or within 2 years |
| Executive or non-independent director in the group | Now or within 2 years |
Each INED confirms independence against every factor; for a new applicant the confirmation appears in the Application Proof, each later draft and the listing document (r.3.13). A candidate caught by a factor can still be appointed if the issuer demonstrates independence before the appointment and discloses why (r.3.14).
Caps with transition. An INED may not hold more than six Main Board or GEM directorships (r.3.12A; holders above six have until the first AGM on or after 1 July 2028). An INED may not stay on beyond the AGM that follows the end of a nine-year tenure (r.3.13A; phased in at AGMs on or after 1 July 2028 and 1 July 2031). For an INED appointed before listing, the 9 years run from the listing date; breaks of under 3 years count; reappointment needs a 3-year gap from any directorship in the group.
Trap: using one look-back period for every factor. Advisers, family connections and executive roles look back 2 years; business dealings look back only 1 year.
Takeaway: 3 INEDs and one-third of the board. Red flags: over 1% (with options), adviser or executive within 2 years, dealings within 1 year.
Filing the application: Form A1, Application Proof and returns
The sponsor lodges the application and deals with the Exchange on everything arising from it (r.9.02). It cannot be filed less than 2 months after the sponsor's formal appointment, or the last sponsor's where there are several (r.3A.02B).
- •What is filed: Form A1, completed by the sponsor, with the Application Proof, the documents in r.9.11(1)-(17d) and the initial listing fee (rr.9.03(1), 9.10A(1)). Form A1 carries a draft timetable the Exchange must agree; the applicant updates the Exchange on progress every fortnight (r.9.03(2)).
- •Substantially complete: the Application Proof must reach the standard of a ready-to-publish listing document, except information that by its nature can only be finalised later (r.9.03(3); Guide 6.2). Offer price, number of offer shares, underwriters' identities and cornerstone details may be omitted. The sponsor's fee and the overall coordinator's identity may not be omitted, though they may sit in square brackets.
- •Accuracy: the applicant and each director ensure the Application Proof is accurate and complete in all material respects and not misleading or deceptive (r.9.03(3A)(a)).
- •Return: if the materials are not substantially complete, the Exchange stops reviewing and returns them. A new Form A1 and Application Proof may be filed only 8 weeks after the Returned Date (r.9.03(3)). The names of the applicant, sponsor and other professional parties, and the reasons, are published whether the filing was public or non-public (Guide 6.2).
- •Fee: refunded if the application is returned before the first comment letter; otherwise forfeited (Note 2 to r.9.03(1)). If an estimated value was used to calculate it, any shortfall is paid before dealings commence (Note 1).
- •Authority: filing the form and Application Proof, issuing the securities, CCASS admission and the listing document must all be approved by board and, where needed, shareholder resolutions (r.9.03(6)).
- •New form needed: if the timetable slips and more than 6 months pass from the date of Form A1, the fee is forfeited and reactivation needs a new form and fee. A change in sponsor, including adding or removing one, also needs a new form and fee (r.9.03(1)). An added sponsor confirms it fully agrees with all earlier submissions (r.9.10B(2)). Refiling within 3 months of a lapse with at least one original independent sponsor keeps earlier documents valid (Note 2 to r.9.10A(1)).
- •Public or non-public filing: the applicant may elect to publish its Application Proof on the Exchange's website (a Public AP) or not, and may switch to publishing an updated proof any time before its Post Hearing Information Pack (r.12.01A and Note; Guide 6.4). Non-public filing has been open to every new applicant since 24 July 2026; before that it was limited to Chapter 18A and 18C companies, eligible secondary listing applicants and case-by-case waivers (HKEX consultation conclusions, July 2026).
1. A sole sponsor is formally appointed on 2 January. When is the earliest Form A1 filing?
Not less than 2 months after the formal appointment, so from 2 March, and only if all the appointment terms were also agreed at least 2 months earlier (r.3A.02B; Code of Conduct para 17.11(b)).
2. Form A1 is dated 10 January and the timetable slips. When does it lapse?
Once more than 6 months have passed from its date. Reactivation then needs a new Form A1 and a new fee (r.9.03(1)).
3. The Exchange returns the Application Proof before issuing its first comment letter. Is the initial listing fee refunded?
Yes. A return before the first comment letter refunds the fee; after that it is forfeited (Note 2 to r.9.03(1)).
4. Does choosing a non-public filing keep a return private?
No. The return, the parties' names and the reasons are published whichever filing route was used (Guide 6.2).
Trap: assuming a non-public filing keeps a return private. A return is always published with the parties' names and the reasons.
Takeaway: Substantially complete or returned; refile after 8 weeks; Form A1 lapses after 6 months; new or added sponsor: new Form A1 and fee.
Vetting to dealings: hearing, timetable and dealing ban
During vetting each revised proof must deal with every comment on the previous proof; the Exchange may decline to review one that is revised piecemeal (r.9.03(5)). Amended documents are resubmitted marked to show where Appendix D1A items are met and what changed (r.9.05). The Exchange may require the expected hearing date to be delayed if the revised proof, outstanding documents and answers to its queries cannot be in at least 4 clear business days before it (r.9.03(4)), and may refuse an application or change the timetable to keep an orderly new issues market (r.9.04).
| Stage | What happens (source) |
|---|---|
| Sponsor appointed | Engagement letter to the Exchange as soon as practicable; filing no earlier than 2 months later (rr.3A.02A, 3A.02B) |
| Filing | Form A1, Application Proof, r.9.11(1)-(17d) documents and fee; the SFC receives a copy under dual filing (rr.9.03, 9.10A; Cap. 571V s.5) |
| Vetting | Comments from the Exchange and the SFC; complete revised proofs; fortnightly progress updates (r.9.03(2), (5)) |
| Hearing | Listing Committee considers the application; dealing ban on core connected persons from 4 clear business days before (r.9.09(b)) |
| After the hearing | Post Hearing Information Pack once the directors conclude material comments are addressed (r.12.01B; Guide 6.4) |
| Prospectus | Authorisation application by 11 a.m. on the intended date; registration by the Registrar of Companies (r.9.11(33); Cap. 32 s.38D) |
| Offer and dealings | Formal notice, offer period, allotment results, dealings begin (Chapter 12) |
Target review time. Under the SFC and Exchange joint statement of 18 October 2024, for an application that fully meets the requirements, each regulator aims to finish its assessment of material regulatory concerns within 40 business days and at most two rounds of comments; eligible large A-share companies (market capitalisation of at least HK$10bn) get 30 business days and one round. The targets fall away if the regulators have material concerns, new material developments arise or replies to comments are incomplete. They are stated aims, not Listing Rules.
No material amendment to the final proof is allowed without the Exchange's consent (r.9.06). The listing document cannot be issued until the Exchange has no further comments, but a draft clearly marked as subject to the Exchange's final review may circulate to arrange underwriting (r.9.07).
Dealing ban (r.9.09). No core connected person (such as a director, the chief executive or a substantial shareholder, or their close associates) may deal in the securities for which listing is sought from 4 clear business days before the expected hearing date until listing is granted, except under r.7.11 to achieve the public float. Directors must report any dealing they learn of; dealing by a director or close associate can lead to rejection. The ban generally stops applying once the application lapses (Guide 4.14).
Trap: starting the ban at filing. For a new applicant it starts 4 clear business days before the expected hearing date; for a listed issuer's application it starts at formal application.
Takeaway: Revised proofs answer every comment. Core connected persons: no dealing from 4 clear business days before the hearing until listing is granted.
Listing document content (Chapter 11 and Appendix D1A)
Overriding principle (r.11.07): the listing document must contain the information an investor needs to make an informed assessment of the issuer's activities, assets and liabilities, financial position, management and prospects, its profits and losses, and the rights attaching to the securities. A new applicant's document must also contain every item in Appendix D1A (r.11.06). The Exchange may require more or allow omissions in a particular case (r.11.11).
- •When needed: offers for subscription or sale, placings of a class new to listing, introductions (including GEM transfers), rights issues, open offers, capitalisation issues, exchanges or substitutions and deemed new listings (r.11.04).
- •Responsibility: every director, and any proposed director named in it, accepts responsibility for the information (r.11.12); the D1A para 2 statement says the directors collectively and individually accept full responsibility.
- •Selected D1A items: total fees paid or payable to the sponsor (para 3A); controlling shareholders and how the issuer is satisfied it can carry on business independently of them (para 27A); directors' working capital statement for at least 12 months from publication (para 36); material litigation or a negative statement (para 40); biographies of directors and senior managers, including anything bearing on ability or integrity such as public sanctions by regulators (para 41).
- •Confidential investigations: if a director is under an investigation that may not legally be disclosed, the director and sponsor assess its relevance to competence or integrity and seek the authority's consent to disclose it to the Exchange and in the listing document. Leaving out relevant details breaches para 41(1) (Guide Annex B.5).
- •Profit forecasts: no reference to future profits unless backed by a formal profit forecast (r.11.16). A profit forecast includes any statement that explicitly or implicitly quantifies future profits, including by reference to previous profits. The issuer decides with its sponsor in advance; the reporting accountants report on the accounting policies and calculations, and the sponsor reports that the directors made it after due and careful enquiry (r.11.17). The period normally ends at the financial year end (r.11.18).
- •Supplementary listing document: if, after issue and before dealings, a significant change or a significant new matter arises, the issuer submits it to the Exchange for review and issues a supplementary listing document once the Exchange has no further comments, unless the Exchange agrees otherwise (r.11.13).
- •Language and disclaimer: English with a Chinese translation (r.11.14); the HKEX and SEHK no-responsibility disclaimer on the front or inside front cover (r.11.20).
Trap: treating Appendix D1A as the whole test. A document that ticks every item can still fail the r.11.07 overriding principle, and "better than last year" is a profit forecast.
Takeaway: Every D1A item plus what an investor needs for an informed assessment; directors take responsibility; supplement any significant change before dealings.
Dual filing with the SFC (Cap. 571V)
Under the Securities and Futures (Stock Market Listing) Rules, an applicant files a copy of its listing application with the SFC within one business day after submitting it to the Exchange (Cap. 571V s.5(1)). It complies on the day of submission if it authorised the Exchange in writing to file for it (s.5(2)); r.11.02A deems every applicant to give that authorisation. The application must comply with the Exchange's rules and the law and contain what an investor needs for an informed assessment (s.3).
| SFC power | Time limit or trigger (Cap. 571V) |
|---|---|
| Require further information | By notice within 10 business days of filing (s.6(1)); not after it has said it does not object (s.6(8)) |
| Object to the listing | Within 10 business days of filing, or of the further information being supplied if it asked for it (s.6(2), (6)); with reasons (s.6(7)) |
| Grounds for objection | Application does not comply with s.3; materially false or misleading, including by omission; information request not met or answered falsely; not in the interest of the investing public or the public interest (s.6(2)) |
| Say it does not object, with or without conditions | Within the same period (s.6(3)) |
| Direct a suspension of dealings | Where materially false, incomplete or misleading information appears in a listing document or announcement, or for an orderly market or investor protection (s.8) |
The Exchange may list the securities only if the SFC has not objected or imposed conditions within the period, has said it does not object, or its conditions are met (s.6(4)). An objection or condition takes effect immediately (s.6(5)). Listed issuers also file announcements and circulars with the SFC within one business day, or through the Exchange (s.7).
Upcoming change · Expected Q1 2027
The SFC's consultation conclusions of 12 October 2026 will amend Cap. 571V. The SFC will be able to withdraw an objection so the applicant need not refile, impose conditions that continue after listing, and impose conditions on a listed company as an alternative to directing a suspension (new s.7A). The amendments go to the Legislative Council for negative vetting; until they commence, the current s.6 and s.8 powers described above apply.
Trap: thinking dual filing makes the SFC the listing authority. The Exchange decides; the SFC can object or attach conditions, and its 10-business-day clock restarts when the further information it asked for is supplied.
Takeaway: Copy to the SFC within one business day (or via the Exchange). The SFC objects within 10 business days; an information request restarts the clock.
Publicity and publication (rule 9.08 and Chapter 12)
No publicity material on an issue of securities by a new applicant may be released in Hong Kong until the Exchange has reviewed it and has no comments (r.9.08). Promotion of the issuer or its products, rather than its securities, is outside the rule. A Public AP, Post Hearing Information Pack, OC Announcement and no-reliance statements need no prior review.
- •Any publicity or announcement before the Listing Committee meeting must state that a listing application has been or will be made (r.9.08(3)).
- •Leaks: if the applicant or its advisers let information leak, the Exchange will normally delay the application. Material released without review before the hearing can delay the hearing by up to a month; if that leaves Form A1 more than 6 months old, the applicant refiles with a new fee (r.9.08(4)).
- •Post Hearing Information Pack (PHIP): every new applicant publishes one (r.12.01B), after the post-hearing letter and once its directors conclude the material comments have been addressed (Guide 6.4). Published APs and PHIPs are redacted so they are not a prospectus or advertisement under the C(WUMP)O or an invitation under s.103 of the SFO.
- •Formal notice: on the date of issue of the listing document for an offer for subscription or sale, or a placing with an amount made available directly to the public (r.12.02); at least 2 clear business days before dealings for other placings and introductions (r.12.03). It names the sponsor and states that application for listing has been made (r.12.04).
- •Listing document: published electronically on the Exchange's website and the issuer's own website (r.12.11).
- •Allotment results for a new listing: by 11:00 p.m. on the business day before listing (r.12.08(1)).
Trap: assuming everything published before the hearing needs Exchange clearance. A Public AP, PHIP and OC Announcement go up without prior review; an interview or press release promoting the offer does not.
Takeaway: No offer publicity before Exchange review; PHIP is compulsory; formal notice on issue for public offers, 2 clear business days before dealings for introductions.
Restrictions around a new listing (Chapter 10)
Chapter 10 keeps the IPO fair to outside investors and the shareholding stable just after listing.
| Who | Restriction | Rule |
|---|---|---|
| Employees, past employees, their dependants and staff trusts | Normally no more than 10% of the securities being marketed on a preferential basis; Exchange approval before marketing; separate application forms | rr.10.01-10.02 |
| Directors and their close associates | May subscribe or buy in the IPO only if nothing is offered or allocated to them preferentially and the minimum public float under r.8.08(1) is met | r.10.03 |
| Existing shareholders | The same two conditions | r.10.04 |
| Controlling shareholders named in the listing document | No disposal from the disclosure date until 6 months after dealings begin; for the next 6 months, no disposal that would end control. A pledge to an authorised institution for a bona fide commercial loan is allowed | r.10.07 |
| Controlling shareholders (undertaking) | For 12 months after dealings begin, tell the issuer at once of any pledge or charge and of any indication that pledged shares will be sold; the issuer announces it | Note 3 to r.10.07(2) |
| The issuer | No new shares or convertibles, and no sale or transfer of treasury shares, or agreement to do so, within 6 months of dealings starting, even if completion falls later. Exceptions: Chapter 17 share schemes, IPO warrants, capitalisation issues, capital reductions, consolidations and sub-divisions, agreements made before dealings and disclosed in the listing document | r.10.08 |
| Issuer, directors, sponsors, underwriters | Take reasonable steps to identify and reject multiple or suspected multiple applications | r.10.09 |
An offer for sale contained in the listing document is outside the controlling shareholder lock-up (r.10.07(1)).
Trap: reading the second 6 months as a full lock-up. From month 7 to month 12 a controlling shareholder may sell, provided it is still a controlling shareholder afterwards.
Takeaway: Directors and existing shareholders: no preference, public float met. Controlling shareholders: 6 plus 6 months. Issuer: no new shares or agreements for 6 months.
The Guide for New Listing Applicants
HKEX's Guide for New Listing Applicants (current edition July 2026) consolidates all currently effective guidance letters, listing decisions and frequently asked questions on new listings. It explains how the Exchange interprets the Listing Rules and the disclosure standard it expects, so that investors can make a properly informed assessment.
- •Structure: six chapters (eligibility and suitability; special listing regimes; listing document disclosure; specific topics; other listing structures; other matters) plus Annex A (listing decisions) and Annex B (FAQs).
- •Status: it does not override the Listing Rules; where they conflict, the Rules prevail. It is not exhaustive and not a checklist for listing document content. The Exchange may ask for more, impose conditions, or waive requirements case by case. The English version prevails over the Chinese.
- •Consequence: the Exchange expects applicants and advisers to follow it; failing to do so can lead to the application being returned or rejected.
- •Pre-IPO enquiries: for novel and specific questions on interpreting the Rules, with e-Form M119. A sponsor must not use them to pre-vet the listing document or to shift its duty to file a substantially complete Application Proof (Guide 6.3). The Exchange gives no overall view on eligibility and suitability before a full application (Guide Chapter 1).
- •Red flags: where vetting finds red flags, such as materially inconsistent disclosure, the Exchange applies a higher standard of review and expects more assurance from the sponsor and experts (Guide Chapter 1).
- •How sponsors use it: as the working reference for each stage, from eligibility and suitability, through what each listing document section should say and what an Application Proof may omit, to publication and prospectus registration.
Trap: treating the Guide as a safe harbour or as overriding the Rules. Following it does not guarantee suitability, and the Rules win any conflict.
Takeaway: One consolidated Guide; the Listing Rules prevail; not a checklist; ignoring it risks return or rejection.
Paper 15: Accountants' report and the six-month rule
Chapter 4 of the Main Board Listing Rules sets the accountants' report. For a new applicant it covers the results of each of the three financial years before the listing document, or a shorter period the Exchange accepts (r.4.04(1)), plus the statement of financial position, cash flows and changes in equity. It is prepared by independent reporting accountants (r.4.03), under HKFRS, IFRS or (for PRC issuers that use it) CASBE applied consistently (r.4.11), states that it follows HKSIR 200, and is named and dated (r.4.08).
| Point | Requirement | Source |
|---|---|---|
| Six-month rule | Latest period reported on must not end more than six months before the listing document date; applies to any supplemental listing document too | r.8.06; Guide 3.11 para 9 |
| Stub period | Audited by the reporting accountants; comparatives at least reviewed; MD&A in the same table | Guide 3.11 paras 10-11 |
| No excuse | Market conditions, an unexpected hearing delay by the Exchange or the burden of updating are not grounds for missing the six-month rule | Guide 3.11 footnote 15 |
| Acquisitions after the latest audited date | Results and financial position of the business for three years (r.4.04(2), (4)); if a binding deal completes after listing, completion escapes Chapter 14/14A steps when the prospectus gave this information and nothing material changed | r.4.04 Note (1) |
| Waiver of r.4.04(2)/(4) | Factors: all percentage ratios under 5%, an SFC exemption if IPO proceeds fund it, and either no control over the target or information unavailable and unduly burdensome | r.4.04 Note (4) |
| Material acquisition inside the track record | If it would be a major transaction (25% or more) or a very substantial acquisition, disclose pre-acquisition figures from the start of the track record to the acquisition date | r.4.05A |
| Working capital | Directors' statement for at least 12 months; the sponsor's advanced draft letter filed with the Application Proof need not include lenders' written confirmation, the final letter must | App. D1A para 36; r.9.11(28); Guide 3.11 |
After the track record period, the directors state whether there has been any material adverse change, and quantitative post-period figures must be reviewed by the reporting accountants (Guide 3.11 para 12).
Trap: measuring the six months to the planned date. The test runs to the actual date of the listing document; if the hearing slips past it, the stub must be updated, whoever caused the delay.
Takeaway: Three years plus an audited stub ending within six months of the prospectus date; major-sized track-record acquisitions need pre-acquisition figures.
Paper 15: Compliance, internal controls and lock-ups
The Guide for New Listing Applicants (chapter 1.2D) sorts non-compliance into three kinds. Material non-compliance has, or is likely to have, a material financial or operational impact; systemic non-compliance is not material but recurring; the rest is immaterial.
| Type | Rectification | Disclosure |
|---|---|---|
| Material | Normally fully rectified before listing, unless not applicable or possible | Standalone sub-section of Business, summary and risk factor; enhanced internal controls (expected in place before listing); directors' and sponsor's view on their adequacy |
| Systemic | Generally not required; directors and sponsor decide | Same disclosure as material |
| Immaterial | Generally not required | As needed |
If the reporting accountants carry out an internal control review, it may be treated as private advice and not quoted in the prospectus; a separate assurance engagement lets it be referenced (Guide 3.7).
Ongoing obligations start at listing. A compliance adviser is kept until the issuer publishes results for the first full financial year after listing (r.3A.19). Controlling shareholders named in the prospectus may not dispose of shares until 6 months after dealings begin, and for the next 6 months may not dispose so as to lose control (r.10.07(1)); the issuer may not issue new shares for 6 months (r.10.08).
| Stock lending for over-allocations (r.10.07(3)) | Condition |
|---|---|
| Disclosure | Fully described in the IPO prospectus; only to cover short positions before the over-allotment option is exercised |
| Size | No more than the shares issuable on full exercise of the option |
| Return | Same number returned within 3 business days after the last exercise day, or full exercise if earlier |
| Payment | None to the controlling shareholder |
Trap: assuming a lending fee is harmless. Any payment to the controlling shareholder, or a loan larger than the option, puts the loan inside the lock-up.
Takeaway: Fix material breaches before listing; disclose systemic ones with controls in place. Greenshoe stock lending is exempt only on all rule 10.07(3) terms.
Paper 15: Public float after listing (from 1 January 2026)
Public float is a continuing obligation, not only a listing test. HKEX's ongoing public float rules took effect on 1 January 2026 for every listed issuer (consultation conclusions of 17 December 2025, with Guidance Letter HKEX-GL121-26 from the same date). A sponsor structuring an IPO should treat the float fixed at listing as the issuer's floor for life.
| Point | Rule from 1 January 2026 |
|---|---|
| Prescribed threshold | Keep, at all times, the public float percentage that applied at listing: 25%, or the lower percentage prescribed when the issuer listed (for example under the r.8.08(1) bands in force since 4 August 2025) |
| Alternative threshold | At least 10% of the class in public hands and a public holding worth more than HK$1 billion, both at once. It only helps issuers worth more than HK$4 billion, since 25% of HK$4 billion is HK$1 billion. Not for A+H issuers, which have their own test |
| A+H issuers | H shares in public hands of at least 5% of the total issued shares of the class, or worth more than HK$1 billion |
| Shortfall | Trading is no longer suspended for a shortfall alone. An issuer with a significant shortfall (judged on both percentage and value) carries a '-PF' marker at the end of its stock name |
| Restore or delist | Delisted if public float is not restored within 18 months (GEM: 12 months) |
| Reporting | Every issuer confirms compliance in its monthly returns and annual report. An issuer in shortfall announces it on becoming aware, updates monthly, and with its directors must not take steps that lower the float further unless circumstances are exceptional |
Planning points for the Principal: a later share buy-back, a controlling shareholder buying more shares after the lock-up, or a placing to an existing core connected person all reduce the float, so the listing-time percentage needs headroom.
Trap: carrying the old regime forward. A shortfall no longer means automatic suspension, and the ongoing floor is the percentage set at listing, which since August 2025 may be below 25%.
Takeaway: From 1 January 2026: keep the listing-time float, or 10% plus HK$1 billion. Significant shortfall: '-PF' marker, 18 months to fix (GEM 12).
Paper 15: Pre-IPO investments and cornerstone investors
Pre-IPO investors often get better terms than IPO investors. Guide chapter 4.2 stops them doing so without bearing different risk. The Exchange normally delays the first day of trading until 120 clear days after completion of the last pre-IPO investment (the 120 Day Delay) if it completed within 28 clear days before the first listing application form and the investor is still a shareholder then, or completed on or after that filing. Completion means the funds are irrevocably received; clear days exclude the completion, filing and first trading days.
| Special right | At listing (Guide 4.2 para 13) |
|---|---|
| Price adjustment based on a discount to the IPO price or market cap | Must end, whoever settles it |
| Fixed return paid by a shareholder, not linked to IPO price | May survive |
| Veto over major corporate actions; prior-consent rights | Must end |
| Director appointment right granted by the applicant | Must end |
| Anti-dilution rights | Must end |
| Information right limited to published information | May survive |
| Right of first refusal or tag-along granted by the controlling shareholder | May survive |
Pre-IPO investors are usually asked to lock up for six months or more, and their shares count in the public float if rule 8.24 is met (Guide 4.2 paras 8-9).
Cornerstone investors (Guide 4.15 paras 27-32) take a guaranteed allocation at the IPO price, pay in full before dealings, are generally locked up for at least six months, have no board seat, are independent of the applicant and its connected persons, and are named in the prospectus. No other benefit may be given by the applicant, controlling shareholder, sponsors or syndicate (for example a put option, brokerage waiver, shared commission or a promise to invest proceeds in the investor's funds). An investor that gets one is treated as a pre-IPO investor. Disclosed arm's length commercial deals, such as supply contracts, are not benefits.
Trap: thinking only investments after filing trigger the delay. Completion within 28 clear days before the first filing also does.
Takeaway: Late pre-IPO money waits 120 clear days. Cornerstones get an allocation at the IPO price and nothing more.
Paper 15: Spin-offs (Practice Note 15)
A listed issuer must submit any proposal to list part of its group separately, in Hong Kong or elsewhere, to the Exchange for approval. Practice Note 15 sets the principles.
| Principle | Rule (PN15 para) |
|---|---|
| Newco | Meets all new applicant requirements, including Chapter 8 (3(a)) |
| Timing | Not normally considered within three years of the Parent's listing; a GEM transferee counts from its original GEM listing date (3(b)) |
| Parent left behind | Must, excluding Newco, keep enough assets and operations to meet Chapter 8 on its own; a profit waiver needs a market-downturn case and HK$80 million aggregate profit in three of the last five years (3(c)) |
| Independence | Clear delineation; Newco independent in directors, management and administration; connected transactions under Chapter 14A (3(d)) |
| Shareholder approval | Needed if any percentage ratio is 25% or more; a controlling shareholder with a material interest abstains; the IFA may not be Newco's sponsor, co-sponsor or underwriter (3(e)) |
| Assured entitlement | Parent shareholders get an assured entitlement to Newco shares, controlling shareholder included; minority shareholders may waive it by resolution (3(f)) |
| Announcement | By the time Newco publishes its PHIP, or its Application Proof if it chooses to publish one (3(g)) |
Upcoming change · Consultation closes 30 November 2026
HKEX's consultation of 21 September 2026 proposes cutting the three-year moratorium to one year, removing the assured entitlement, and letting large parents (market capitalisation of at least HK$10 billion and revenue of at least HK$1 billion, with the retained business above 50% of group revenue and assets) self-assess compliance without the Exchange's prior approval. These are proposals only; the current Practice Note 15 applies until conclusions are published and take effect.
Trap: counting the three years from a Main Board transfer. A former GEM issuer counts from its first GEM listing.
Takeaway: Three years after the Parent lists, a Parent that stands alone, an independent Newco and an assured entitlement for Parent shareholders.
Paper 15: Allocation, clawback and placing rules
Practice Note 18 (revised 4 August 2025) governs IPO allocation. The public subscription tranche is split equally into pool A (applications of HK$5 million or less) and pool B (above HK$5 million, up to the value of pool B); a shortfall in one pool tops up the other, and no one may apply for more than a pool's original allocation (para 3.1). An investor may receive shares in one tranche only (paras 4.5-4.6). At least 40% of the offer, excluding any offer size adjustment and over-allotment option shares, must go to placing tranche investors other than cornerstone investors (para 3.2).
| Public tranche demand (x initial allocation) | Mechanism A share of offer | Mechanism B |
|---|---|---|
| Initial | 5% | At least 10% (maximum 60% because of the 40% floor), no clawback |
| 15x to under 50x | 15% | - |
| 50x to under 100x | 25% | - |
| 100x or more | 35% | - |
Worked example: 500 million shares, Mechanism A, 120x demand. Public tranche 35% (175 million), placing 325 million. Non-cornerstone placees need 200 million (40%), so cornerstones can have at most 125 million (25%).
Where public demand is under the clawback trigger, Reallocation from placing to public is capped at the lesser of double the initial allocation and 15% of the offer, with the price fixed at the bottom of the range (Guide 4.14). Over-allocation is limited to the over-allotment option, which overall coordinators may divide between tranches (PN18 para 4.3).
Appendix F1 (para 1C) bars allocations, without the Exchange's prior written consent, to connected clients of the overall coordinator, syndicate members or distributors (their partners, staff, substantial shareholders, directors, close associates and group companies), to directors or existing shareholders unless rules 10.03 and 10.04 are met, and to nominees whose beneficial owner is not disclosed. Guide 4.15 sets the consent conditions.
| Placee | Guide 4.15 conditions |
|---|---|
| Connected client holding for independent investors | Consent; no preferential treatment; for discretionary holders, the connected distributor stays out of allocation decisions; never for its proprietary account save exceptionally |
| Existing shareholder | Consent and r.10.04 waiver; under 5% of votes, not a core connected person, no right to appoint directors, public float met, allocation disclosed |
| Size-based exemption | Offer of at least HK$1 billion; existing shareholders take no more than 30% of the offer; directors, chief executive and controlling shareholders take none |
1. Mechanism A, public tranche 60 times subscribed. What share of the offer goes to the public tranche?
25% (the 50x to under 100x band).
2. Mechanism B with a 10% initial public allocation, 200 times subscribed. What changes?
Nothing. Mechanism B has no clawback.
3. Offer of 400 million shares under Mechanism A, no clawback triggered. Maximum cornerstone allocation?
Public 5% (20 million) and non-cornerstone placees at least 40% (160 million), so cornerstones take at most 220 million, or 55%.
4. Can one investor receive shares in both the public tranche and the placing tranche?
No. An investor may receive shares in one tranche only (PN18 paras 4.5-4.6).
Trap: measuring demand against the whole offer. Clawback multiples are of the initial public allocation, and the 40% floor excludes cornerstone shares.
Takeaway: 5-15-25-35 at 15x-50x-100x; 40% of the offer to non-cornerstone placees; connected clients and existing shareholders need Exchange consent.
Paper 15: Price stabilisation and overall coordinator duties
Stabilizing action taken in compliance with the Securities and Futures (Price Stabilizing) Rules (Cap. 571W) is not market misconduct or a Part XIV offence (ss.4-5). It is open only for a cash offer at a specified price of at least HK$100 million, excluding over-allocated shares (s.3). The single stabilizing manager may buy to prevent or minimise a fall in price (s.6), and may over-allocate, short sell and exercise the over-allotment option to close out (s.7); exercising the option is free of the price limits (s.7(2)).
| Point | Rule (Cap. 571W) |
|---|---|
| Stabilizing period | From the start of trading until the 30th day after the closing date or start of trading, whichever is earlier (s.2) |
| Price limits | Initial bid: up to the offer price. Later: the lower of the offer price and the initial stabilizing price, or of the offer price and any higher outside deal (Sch. 2); deals by or for the stabilizing manager do not count |
| Agents | Only the stabilizing manager, or an agent it appoints, may bid; it answers for the agent as for itself (s.12) |
| Disclosure | From the first public announcement date (s.8); announcement as soon as practicable after exercising the option (s.9(1)); post-stabilization announcement within 7 days of the period's end (s.9(2)) |
| Register | Kept in Hong Kong or producible within 48 hours; kept 7 years; offerors may inspect trade details (not counterparties) within 3 months; the SFC at any time (ss.13-14) |
Code of Conduct paragraph 21 (December 2025 edition) sets bookbuilding duties. A syndicate CMI makes sure orders are bona fide, queries unusual ones, gives the OC and issuer each underlying investor's name and unique identification number for omnibus orders and uses that information only for that offering (21.3.5). It keeps order-to-allocation audit trails for at least two years and its other records for seven (21.3.9). An OC keeps an allocation policy, makes recommendations with a proper basis aiming at an open market and an adequate spread (21.4.4). If the issuer rejects its pricing or allocation advice, the OC explains the concerns and advises against it (21.4.2(c)), records the decision and its explanation for seven years (21.4.7) and reports material SEHK breaches (21.4.8; App. F1 para 19).
Trap: counting the stabilizing manager's own trades as a higher outside deal, or swapping the two-year and seven-year record periods.
Takeaway: Stabilize at or below the offer price, ratcheting down to outside deal prices. OCs advise, record and escalate when issuers overrule them.
Traps that cost marks
- Calling a spin-off an offer for sale because existing shares change hands, or assuming an introduction needs no listing document.
- Stopping at rule 7.14 (already listed elsewhere) without checking the rule 7.15 factors that can still make an introduction unacceptable.
- Testing the headline profit, or checking only the latest year once it clears HK$35 million.
- Assuming the shorter-record relief applies under the HK$2 billion cash flow test as well.
- Quoting the 10% headline for the top band and forgetting that the HK$4.5 billion value limb often sets a higher percentage.
- Forgetting the concentration test on the three largest public holders, or treating locked-up cornerstone shares as fatal to the public float.
- Applying only the 10% limb and missing the HK$600 million alternative that large issuers rely on.
- Treating the IOSCO MMOU condition as an Exchange-only matter, or treating rule 8.05 as an entitlement to list.
Now test it on exam-style questions
Sit a free, timed quick mock of exam-style questions. Try 5 with no sign-up, then the full mock with a free account.
Start the free mockFull question bank and every mock: see passes
Keep studying HKSI Paper 15
HKSI Paper 15: exam format and practice
Study notes
Exam-style questions
- Orchid Group Ltd, listed on the Main Board, will distribute all its shares in its subsidiary Fern Ltd in specie to Orchid's shareholders. Fern will raise no new money. As the Principal advising on Fern's listing, what do you recommend?
- Beacon plc, primary listed in London, plans to list in Hong Kong by introduction. Its 40% shareholder tells you, as the Principal, that it intends to sell half its stake to Hong Kong investors soon after listing. How does rule 7.15 affect the plan?
- Kestrel Foods Ltd's profit attributable to shareholders was HK$20 million, HK$28 million and HK$38 million (latest). Each year includes HK$2 million of profit from an associate accounted for by the equity method. Management and ownership are unchanged. Does Kestrel meet the profit test?
- Zenith Payments Ltd is loss-making, with a two-year trading record, an expected market capitalisation of HK$3 billion, latest audited revenue of HK$800 million and HK$150 million of operating cash flow. Its directors have five years' industry experience. Can its sponsor rely on rule 8.05A?